Imatinib-induced pancreatitis

Indian Journal of Pharmacology

Volumn 42, Issue 1, 2010, Pages 50-52

  Varma, Mahesh R ^a   Mathew, Shibi ^a   Krishnadas, Devadas ^a   Vinayakumar, K R ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Acute pancreatitis; Chronic myeloid leukemia; Imatinib mesylate

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; C REACTIVE PROTEIN; HEMOGLOBIN; IMATINIB; MARKER; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADULT; ALCOHOL CONSUMPTION; AMYLASE BLOOD LEVEL; ANEMIA; ARTICLE; BILE DUCT DILATATION; CASE REPORT; CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; COMMON BILE DUCT; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPIGASTRIC FULLNESS; EPIGASTRIC PAIN; ERYTHROCYTE SEDIMENTATION RATE; FISTULA; FOOD INTAKE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAHEPATIC BILE DUCT; LIVER FUNCTION TEST; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHILADELPHIA CHROMOSOME POSITIVE CELL; PHYSICAL EXAMINATION; PLEURA EFFUSION; PSEUDOCYST; REMISSION; SMOKING; SPLENOMEGALY; THORACOCENTESIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

EID: 77951671751     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.62407     Document Type: Article

References (12)

1. Forsmark CE, Baillie J; AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007;132:2022-44.
2. Levy P, Mathurin P, Roqueplo A, Rueff B, Bernades P. A multidimensional case-control study of dietary alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas 1995;10:231-8
3. Naranjo C, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 2006;24:460-6.
5. Greenberger NJ, Toskes PPAcute and chronic pancreatitis. Harrison's Online Available from: http://www.accessmedicine.com. [accessed on 2006 May 31]
6. Chari ST, Vege SS. Etiology of acute pancreatitis. In: Up-to-date. Available from http://www.uptodate.com. [accessed on 2006 May 31].
7. Hunter TB, Bjelland JC. Gastrointestinal complications of leukemia and its treatment. AJR Am J Roentgenol 1984;142:513-8
8. Panigrahi I, Naithani R. Imatinib mesylate: A designer drug. J Assoc Physicians ndia 2006:54:203-6.
9. Eland IA, van Puijenbroek EP, Sturkenboom MJ,Wilson JH, Stricker BH. Drug-associated acute pancreatitis: Twenty-one years of spontaneous reporting in The Netherlands. Am J Gastroenterol 1999;94:2417-22.
10. Druker BJ, Guilhot F, O'Brien R A, Larson NS, et al. Long-term benefits of matinib (IM) for patients newly diagnosed with chronic myelogenous leukemia in chronic phase (CML-CP): The 5-year update from the IRIS study. J Clin Oncol 2006;24:338s.
11. Wagner U, Staats P, Moll R, Feek U, Vogelmeier C, Groneberg DA. Imatinib-associated pulmonary alveolar proteinosis. Am J Med 2003;115:674
12. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and Safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7.